Researchers at University of Auckland in New Zealand are working on an innovative way to treat an aggressive blood cance...
While in Geneva to advance Australia’s interests at the World Health Organization’s (WHO) World Health Assem...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has signed a Me...
Traditional chemotherapy often poses significant challenges, including severe side effects, damage to healthy tissue and...
Scientists from Nanyang Technological University, Singapore (NTU Singapore) and Chiba University in Japan have shown how...
Precision medicine is becoming more prevalent, with pharmaceutical companies and healthcare regimen to develop highly ta...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, ...
A randomised, placebo-controlled clinical trial led by a collaboration between Duke-NUS Medical School, National Heart C...
OBiO Technology, a world leading contract development and manufacturing organisation (CDMO) for cell and gene thera...
Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease...
A research team at Osaka University, Japan will start an investigator-initiated clinical trial for refractory prostate c...
Researchers from Duke-NUS Medical School in Singapore have found that a new class of light-sensitive proteins are capabl...
A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovat...
The urgency to address the myopia epidemic among children has never been more pressing. Recent studies reveal an al...
To mark World Clinical Trials Day on May 20, Victorian Deputy Premier and Minister for Medical Research, Ben Carro...
As Asia establishes itself as the global hub for clinical trials, Singapore is bolstering its position as the preferred ...
The Asia Pacific, Middle East and Africa (APMA) region represents almost half of the world's population but healthcare a...
Johnson & Johnson’s first-in-class, bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell-redirectin...
